CMPS NASDAQ
COMPASS Pathways plc
1W: +7.5%
1M: +6.5%
3M: +19.2%
YTD: +53.7%
1Y: +153.0%
3Y: +22.2%
5Y: -71.2%
$10.87
+0.80 (+7.94%)
After Hours: $10.86 (-0.01, -0.14%)
Weekly Expected Move ±24.4%
$5
$8
$10
$13
$15
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$967.6M
52W Range2.25-11.65
Volume4,111,334
Avg Volume4,006,519
Beta2.40
Dividend—
Analyst Ratings
Company Info
CEOKabir Kumar Nath
Employees166
SectorHealthcare
IndustryMedical - Care Facilities
IPO Date2020-09-18
Websitecompasspathways.com
33 Broadwick Street
London W1F 0DQ
GB
London W1F 0DQ
GB
44 64 6905 3974
About COMPASS Pathways plc
COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.
Latest News
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Nath Kabir | A-Award | 367,815 | $5.64 | 2026-03-26 |
| Nath Kabir | A-Award | 175,000 | — | 2026-03-26 |
| Goodwin Guy | A-Award | 115,600 | $5.64 | 2026-03-26 |
| Loxam Teri | A-Award | 157,635 | $5.64 | 2026-03-26 |
| Loxam Teri | A-Award | 75,000 | — | 2026-03-26 |